Low Dose Rosuvastatin Plus Ezetimibe Versus High-dose Rosuvastatin in AMI

Clinical trial NCT04499859 · RECRUITING

Trial details

NCT number: NCT04499859
Sponsor: Kiyuk Chang, MD,PhD
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Myocardial Infarction Statin Adverse Reaction HMG-CoA Reductase Inhibitor Toxicity

Start date: 2020-10-01
Primary completion: 2026-08-30
Enrollment: 3548

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.